Biotechnology and its Applications

The One Thing

Biotechnology applies living organisms, cells, enzymes, and genetic material to produce useful products and processes. Its applications in medicine, agriculture, industry, environmental management, and forensic science require genetic and cellular innovation combined with safety assessment, ethical decision-making, and environmental responsibility.

Reactions, Processes and Experiments

Key Terms

• Biotechnology: The application of biological organisms, cells, enzymes, or genetic material to produce useful goods and services.
• Genetic engineering: The deliberate modification of an organism’s genetic material by inserting, removing, or changing specific genes.
• Recombinant DNA: DNA formed by joining genetic material from two different sources, often using restriction enzymes and DNA ligase.
• Restriction endonuclease: An enzyme that cuts DNA at specific recognition sequences, producing blunt or sticky ends.
• DNA ligase: An enzyme that joins DNA fragments by forming bonds between their sugar-phosphate backbones.
• Cloning vector: A DNA molecule, such as a plasmid or modified virus, used to carry a foreign gene into a host cell.
• Plasmid: A small, circular, self-replicating DNA molecule commonly found in bacteria and frequently used as a vector.
• Polymerase chain reaction: A laboratory technique used to make millions of copies of a selected DNA segment through repeated cycles of denaturation, primer binding, and extension.
• Bioreactor: A vessel that provides controlled conditions for growing cells or microorganisms and producing biological products on a large scale.
• Downstream processing: The purification, separation, quality testing, and formulation of a product obtained from a biotechnological process.
• Recombinant insulin: Human insulin produced by genetically modified microorganisms, allowing large-scale production of a medicine for diabetes.
• Gene therapy: Treatment of disease by introducing, replacing, silencing, or editing genetic material in a patient’s cells.
• Genetically modified organism: An organism whose genetic material has been altered using biotechnology.
• Bt crop: A genetically modified crop containing a gene from Bacillus thuringiensis that produces a protein toxic to certain insect pests.
• Cry protein: An insecticidal protein produced by Bacillus thuringiensis; its gene is introduced into some crops to provide pest resistance.
• RNA interference: A natural or engineered process in which double-stranded RNA prevents the expression of a specific gene by destroying or blocking its messenger RNA.
• Golden rice: A genetically modified rice variety designed to produce beta-carotene, a precursor of vitamin A, in its grain.
• Biopesticide: A pest-control product derived from living organisms or their natural products, such as microbial toxins.
• Biofertiliser: A preparation containing beneficial microorganisms that improve nutrient availability or soil fertility.
• Transgenic animal: An animal carrying and expressing a foreign gene introduced through genetic engineering.
• Molecular diagnosis: Detection of disease-causing organisms, mutations, or abnormal genes using methods such as PCR, DNA probes, or antibody-based tests.
• ELISA: An antibody-based test used to detect specific antigens or antibodies, including those associated with infections.
• Vaccine: A biological preparation that stimulates the immune system to develop protection against a particular pathogen or disease.
• Biopatent: A legal right granted for an invention involving biological material, a biological process, or a biotechnology product.
• Biopiracy: The unauthorised commercial use or patenting of biological resources or traditional knowledge belonging to a community or country.
• Bioethics: The study of moral principles related to biotechnology, including consent, safety, justice, privacy, animal welfare, and environmental responsibility.
• Biosafety: Measures used to prevent harm to humans, animals, and the environment during the development, testing, and release of biotechnology products.
• Cellular totipotency: The ability of a living plant cell to develop into a complete plant under suitable conditions.
• Human Genome Project: An international effort formally completed in 2003 that produced a reference human genome sequence and improved understanding of human genes and genetic variation.
• Precautionary principle: The principle that lack of complete scientific certainty should not justify ignoring a possible risk of serious or irreversible harm.

Easily Confused

• Restriction endonuclease and DNA ligase: Restriction endonucleases cut DNA at specific sequences, whereas DNA ligase joins DNA fragments.
• Biopesticide and biofertiliser: A biopesticide controls pests, whereas a biofertiliser improves nutrient availability or soil fertility.
• Bt crops and RNA interference: Bt crops produce Cry proteins that damage insect larvae, whereas RNA interference silences a specific gene by degrading or blocking matching messenger RNA.
• Biotechnology and genetic engineering: Biotechnology is the broader application of biological systems; genetic engineering specifically involves deliberate modification of genetic material.
• Molecular diagnosis and ELISA: Molecular diagnosis includes methods such as PCR and DNA probes for detecting genes or pathogens, whereas ELISA detects specific antigens or antibodies using an antibody-based test.
• Biopatent and biopiracy: A biopatent is an authorised legal right over a biotechnology invention, whereas biopiracy is unauthorised commercial use or patenting of biological resources or traditional knowledge.
• Bioethics and biosafety: Bioethics concerns moral principles such as consent, justice, privacy, and animal welfare, whereas biosafety concerns preventing harm during biotechnology development, testing, and release.
• Gene therapy and vaccination: Gene therapy introduces or modifies genetic material to address disease, whereas vaccination stimulates immune protection against a pathogen or disease.
• Transgenic animal and genetically modified organism: A transgenic animal is a genetically modified animal carrying and expressing a foreign gene; a genetically modified organism is the broader category.
• Golden rice and Bt crop: Golden rice is modified for improved nutritional quality through beta-carotene production, whereas Bt crops are modified for insect resistance through Cry protein production.

What Gets Asked

• Describe the stages of recombinant DNA technology: include isolation of the desired gene, restriction-enzyme cutting of donor and vector DNA, DNA-ligase joining, introduction into a host cell, selection of transformed cells, and expression and purification. Omitting selection or downstream processing costs marks.
• Explain PCR: state the three stages—denaturation, primer annealing, and extension—and identify the use of a heat-stable polymerase such as Taq polymerase. Do not describe PCR as ordinary cellular DNA replication.
• Explain recombinant human insulin production: identify genetically modified microorganisms and state that mature insulin contains A and B polypeptide chains joined by disulphide bonds. Confusing recombinant insulin with a single unprocessed polypeptide loses specificity.
• Explain Bt crops or RNA interference: Bt crops produce Cry proteins active in the alkaline gut of susceptible insect larvae, whereas RNA interference silences matching genes through double-stranded RNA. Treating the two mechanisms as interchangeable is incorrect.
• Discuss agricultural applications: include GM traits such as insect resistance, herbicide tolerance, improved nutritional quality, delayed ripening, and environmental-stress resistance, together with tissue culture, micropropagation, and biofertilisers such as Rhizobium, Azotobacter, cyanobacteria, and mycorrhizal fungi.
• Evaluate biotechnology ethically and environmentally: refer to toxicity, allergenicity, unintended effects, gene transfer, ecological impact, long-term safety, informed consent, privacy, unequal access, ownership of genetic resources, animal experimentation, germ-line modification, biopiracy, and regulatory oversight in India. The key omission is to present biotechnology as beneficial without addressing these risks.